Emerging evidence suggests that aberrant activation of the TRAIL/TRAILR pathway contributes to IDD, with elevated expression levels of TRAIL and its receptors observed in degenerated NPCs. Here, TNFSF10 is linked to intervertebral disk degenerative disorder.